Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedDec 10, 2025
DataAggregated Company Financials
Companies18
- 7D-1.3%
- 3M-11.9%
- 1Y-20.6%
- YTD-20.1%
In the last week, Healthcare has been flat. As for the longer term, the industry has declined 20% in the last year. Looking forward, earnings are forecast to grow by 12% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 10 Dec 2025 | €20.2b | €8.8b | €886.9m | 19.6x | 22.8x | 2.3x |
| Fri, 07 Nov 2025 | €20.8b | €8.8b | €886.0m | 20.7x | 23.5x | 2.4x |
| Sun, 05 Oct 2025 | €22.9b | €8.8b | €895.5m | 20.8x | 25.6x | 2.6x |
| Tue, 02 Sep 2025 | €23.2b | €8.7b | €902.9m | 19.7x | 25.7x | 2.7x |
| Thu, 31 Jul 2025 | €22.9b | €8.7b | €930.6m | 20.3x | 24.6x | 2.6x |
| Sat, 28 Jun 2025 | €23.4b | €25.2b | €985.5m | 19.7x | 23.8x | 0.9x |
| Mon, 26 May 2025 | €22.7b | €25.2b | €985.5m | 19.3x | 23x | 0.9x |
| Wed, 23 Apr 2025 | €21.4b | €20.1b | €908.1m | 18x | 23.6x | 1.1x |
| Fri, 21 Mar 2025 | €23.0b | €19.6b | €796.9m | 21.3x | 28.9x | 1.2x |
| Sun, 16 Feb 2025 | €26.3b | €20.0b | €828.0m | 23.5x | 31.7x | 1.3x |
| Tue, 14 Jan 2025 | €24.8b | €8.0b | €834.7m | 21.4x | 29.7x | 3.1x |
| Thu, 12 Dec 2024 | €24.7b | €19.0b | €1.4b | 19x | 17.3x | 1.3x |
| Sat, 09 Nov 2024 | €24.8b | €19.0b | €1.4b | 16.5x | 17.8x | 1.3x |
| Mon, 07 Oct 2024 | €25.0b | €18.9b | €1.4b | 17.3x | 18.1x | 1.3x |
| Wed, 04 Sep 2024 | €25.8b | €18.9b | €1.4b | 15x | 18.6x | 1.4x |
| Fri, 02 Aug 2024 | €25.4b | €18.9b | €1.4b | 16.6x | 18.3x | 1.3x |
| Sun, 30 Jun 2024 | €25.6b | €18.8b | €1.4b | 16.4x | 18.5x | 1.4x |
| Tue, 28 May 2024 | €26.1b | €18.8b | €1.4b | 18x | 18.8x | 1.4x |
| Thu, 25 Apr 2024 | €25.6b | €18.7b | €1.4b | 18.9x | 18.6x | 1.4x |
| Sat, 23 Mar 2024 | €25.5b | €18.6b | €1.4b | 20.7x | 18.3x | 1.4x |
| Mon, 19 Feb 2024 | €25.2b | €18.6b | €1.4b | 18.6x | 18.1x | 1.4x |
| Wed, 17 Jan 2024 | €24.6b | €18.6b | €1.4b | 18.3x | 17.7x | 1.3x |
| Fri, 15 Dec 2023 | €24.8b | €18.6b | €1.4b | 18.4x | 17.8x | 1.3x |
| Sun, 12 Nov 2023 | €22.5b | €18.6b | €1.4b | 16.9x | 16.2x | 1.2x |
| Tue, 10 Oct 2023 | €22.3b | €18.6b | €1.4b | 16.8x | 15.4x | 1.2x |
| Thu, 07 Sep 2023 | €23.3b | €17.3b | €1.1b | 15.8x | 20.4x | 1.3x |
| Sat, 05 Aug 2023 | €23.3b | €7.8b | €857.4m | 14.9x | 27.2x | 3x |
| Mon, 03 Jul 2023 | €24.3b | €7.7b | €822.5m | 17.5x | 29.5x | 3.1x |
| Wed, 31 May 2023 | €23.8b | €7.7b | €822.5m | 21.9x | 28.9x | 3.1x |
| Fri, 28 Apr 2023 | €23.9b | €7.6b | €826.9m | 21.6x | 28.9x | 3.2x |
| Sun, 26 Mar 2023 | €23.0b | €7.6b | €868.1m | 19.1x | 26.5x | 3x |
| Tue, 21 Feb 2023 | €23.9b | €7.4b | €886.1m | 24.4x | 27x | 3.2x |
| Thu, 19 Jan 2023 | €24.6b | €7.4b | €886.1m | 24.4x | 27.8x | 3.3x |
| Sat, 17 Dec 2022 | €23.8b | €7.4b | €886.1m | 22.7x | 26.9x | 3.2x |
Price to Earnings Ratio
26.9x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 22.9x.
- The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | 0.31% | |
| Healthcare | -1.32% | |
| Life Sciences | 2.55% | |
| Healthtech | 1.93% | |
| Healthcare Services | 0.42% | |
| Biotech | 0.054% | |
| Medical Equipment | -0.20% | |
| Pharma | -2.87% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 55.8x.
- Analysts are expecting annual earnings growth of 24.9%, which is lower than the prior year's growth of 116.9% per year.
- Investors are most pessimistic about the Life Sciences industry, which is trading below its 3-year average of 33.8x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 25% over the next 5 years.
- However this is lower than its past earnings growth rate of 117% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 77% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AMP Amplifon | €13.39 | 1.5% +€42.9m | -46.2% | PE25.5x | |
| GPI GPI | €16.92 | 1.9% +€9.2m | 58.1% | PE30.8x | |
| FF Fine Foods & Pharmaceuticals N.T.M | €9.66 | 2.5% +€5.9m | 23.5% | PE18.9x | |
| ELN EL.En | €12.95 | 0.5% +€4.8m | 7.0% | PE19.6x | |
| SVS Svas Biosana | €8.64 | 3.8% +€1.7m | 27.1% | PE6.8x |
